Velocity Clinical Research

Durham, United States Founded: 2017 • Age: 9 yrs Acquired By GHO Capital Partners
Provider of site management and patient recruitment services

About Velocity Clinical Research

Velocity Clinical Research is a Healthcare company based in Durham (United States) founded in 2017, and was acquired by GHO Capital Partners in April 2021. Provider of site management and patient recruitment services. Velocity Clinical Research has completed 9 acquisitions, including Clinical Research Hamburg, Clinical Research Institute and Egin Research. Its website velocityclinical.com draws about 276 thousand monthly visits. Velocity Clinical Research offers products and services including Clinical Trial Sites and Patient Recruitment. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Elligo, Acurian and CenExel; 2 of its 3 listed competitors have raised funding.

Company details

Velocity Clinical Research was founded in 2017 and is headquartered in Durham, United States. Clinical trials are conducted by the company within the healthcare sector, with services centered on site management and patient recruitment. Focus is placed on therapeutic areas including allergy, immunology, Alzheimers disease, biologic therapies, cardiovascular conditions, dermatology, endocrinology, metabolism, and gerontology. Operations support research across multiple medical fields.

  • Headquarters Durham, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website velocityclinical.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by GHO Capital Partners (Apr 2021)
Key Metrics

Products & Services of Velocity Clinical Research

Velocity Clinical Research offers a comprehensive portfolio of products and services, including Clinical Trial Sites and Patient Recruitment.

Clinical Trial Sites
Research Services

Manages sites for conducting clinical trials efficiently

Patient Recruitment
Engagement Services

Recruits and retains participants for medical studies

Investors in Velocity Clinical Research

Velocity Clinical Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GHO Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Specialist healthcare investment advisory services are provided by GHO Capital.
ghocapital.comLondon, United Kingdom
Premium access

Investor details for Velocity Clinical Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Velocity Clinical Research

12 people are tracked at Velocity Clinical Research (11 in leadership, 1 in team).

NameRoleGroup
Kimberly Ballard
Chief People OfficerLeadership
Steph Anderson
Chief Of Staff •Leadership
Paul Evans
President And Chief Executive OfficerLeadership
Laura Falcone
Chief Strategic Delivery OfficerLeadership
Brandi Lang
Chief Legal OfficerLeadership
Nick Campbell
Chief Commercial OfficerLeadership
Nick …
Chief Operations OfficerLeadership
Jeffrey Jensen
Chief Growth OfficerLeadership
Raghu Punnamraju
Chief Technology OfficerLeadership
Dominic Clavell
Executive Vice President, EuropeLeadership
Stephanie Anderson
Chief Of StaffLeadership
Shelley Ireland
Regulatory SpecialistTeam
Premium access

Complete people profiles for Velocity Clinical Research

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Velocity Clinical Research

Velocity Clinical Research has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Clinical Research Hamburg, Clinical Research Institute and Egin Research.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of phase I-IV clinical trials services
mcrmed.comOmaha, United States1999Dec 2022β€’β€’β€’β€’
Provider of clinical trial & research and patient recruitment services for pharmaceutical industry
eginresearch.comHigh Wycombe, United Kingdom2019Nov 2022β€’β€’β€’β€’
Clinical trial management and data collection services are offered.
medpharmics.comMetairie, United States2012Sep 2022β€’β€’β€’β€’
Provider of clinical research of phases II, III and IV from different indications spheres of human medicine
crh-hamburg.deHamburg, Germany2004Jul 2022β€’β€’β€’β€’
AI and blockchain-based clinical trials management software is provided.
trierhealth.comSan Jose, United States2019Feb 2022β€’β€’β€’β€’
Site Management Organization with expertise in conducting infectious disease trials
estudysite.comSan Diego, United States1999Nov 2020β€’β€’β€’β€’
Diagnostic methods and treatments are developed through clinical research efforts.
clinicalresearchso.comMedford, United States2008Feb 2019β€’β€’β€’β€’
Medical research is conducted through clinical laboratory operations.
nhcr.comCincinnati, United States1988Feb 2019β€’β€’β€’β€’
Clinical trials and medical investigations are conducted by MD Clinical.
mdclinical.orgHallandale Beach, United States2005Dec 2018β€’β€’β€’β€’
Premium access

Complete acquisition details for Velocity Clinical Research

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Velocity Clinical Research

11 dated milestones of Velocity Clinical Research across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Velocity Clinical Research is founded.
  2. Acquisition Acquires MD Clinical.
  3. Acquisition Acquires Clinical Research Institute.
  4. Acquisition Acquires New Horizons Clinical Research.
  5. Acquisition Acquires eStudySite.
  6. Exit Acquired by GHO Capital Partners.
  7. Acquisition Acquires TrierHealth.
  8. Acquisition Acquires Clinical Research Hamburg.
  9. Acquisition Acquires MedPharmics.
  10. Acquisition Acquires Egin Research.
  11. Acquisition Acquires Meridian Clinical Research.

Competitors of Velocity Clinical Research

Velocity Clinical Research has 3 listed competitors in our database, 2 of them funded. They include Elligo, Acurian and CenExel.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
elligohealthresearch.com2016Austin, United States$176.48M280
Patient recruitment and site activation services are provided by Elligo.
acurian.com1998Horsham, United States$27M
Patient enrollment and retention solutions for clinical trials are offered.
cenexelresearch.com2019Salt Lake, United States451
Research site management and patient recruitment services are provided.
Premium access

Detailed competitors of Velocity Clinical Research

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Velocity Clinical Research

The website of Velocity Clinical Research (velocityclinical.com) receives about 275.5K visits a month and ranks #102,227 among all websites worldwide, #2,949 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    275.5K

    ▼ 49.4% vs previous month

  • Unique visitors
    258.2K

    per month

  • Global rank
    #102,227

    among all websites

  • Category rank
    #2,949

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Velocity Clinical Research. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lindushealth.com
100%
62.9K#570,947View details
cenexelresearch.com
97%
192.4K#173,930View details
velocityclinicaltrials.com
velocityclinicaltrials.com
75%
#345,093–
spartanburgent.com
spartanburgent.com
72%
#1,756,122–
kp-scalresearch.org
kp-scalresearch.org
63%
#1,229,601–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 18 similar websites and full traffic analytics for Velocity Clinical Research

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 18 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Velocity Clinical Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Velocity Clinical Research

Premium access

Complete news archive for Velocity Clinical Research

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Velocity Clinical Research

Velocity Clinical Research was founded in 2017.

Velocity Clinical Research is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Velocity Clinical Research was founded in 2017 and is headquartered in Durham, United States. Clinical trials are conducted by the company within the healthcare sector, with services centered on site management and patient recruitment. Focus is placed on therapeutic areas including allergy, immunology, Alzheimers disease, biologic therapies, cardiovascular conditions, dermatology, endocrinology, metabolism, and gerontology. Operations support research across multiple medical fields.

Velocity Clinical Research's top competitors include Elligo, Acurian and CenExel.

Velocity Clinical Research offers Clinical Trial Sites and Patient Recruitment.

Velocity Clinical Research has made 9 acquisitions, including Clinical Research Hamburg, Clinical Research Institute, and Egin Research.

Velocity Clinical Research has 1 investor. Key investors include GHO Capital.

Yes. Velocity Clinical Research was acquired by GHO Capital Partners in April 2021.

The website of Velocity Clinical Research receives about 276 thousand visits a month and ranks #102,227 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available